Sato Pharmaceutical Inc. recalls Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S.
Recalled November 20, 2019 · FDA recall D-0323-2020 · Sato Pharmaceutical
Hazard
Subpotent Drug · FDA Class III
Units
210,744 units
Sold at
Nationwide within the United States, Guam and Saipan
Description
Subpotent Drug
Product
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Manufacturer(s)
Sato Pharmaceutical Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →